AI-enabled Living Labs: Accelerating innovation in multiple sclerosis care and research
Multiple Sclerosis Journal · 2026-04 · 32 (5) · 451-458
DOI: 10.1177/13524585261424136 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Multiple Sclerosis Journal, online erschienen am 13.03.2026. Verfasst von Hernan Inojosa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center of Clinical Neuroscience, Department of Neurology, Faculty of Medicine and University Hospital Carl Gustav Carus Dresden, TUD Dresden Universi…. Hauptthemen laut MEDLINE: Artificial Intelligence, Multiple Sclerosis, Biomedical Research. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The rapid rise of artificial intelligence (AI) and digital health technologies presents new opportunities for personalized care in multiple sclerosis (MS). However, implementation in routine practice is limited by regulatory hurdles, fragmented infrastructure and a lack of agile real-world evaluation methods. Living Labs (LLs) emerge as dynamic environments for advancing MS care and research, supporting early testing and iterative development of digital tools, while fostering structured collaboration among patients, clinicians, researchers and regulators. In this review, we conceptually frame LLs in MS and provide a concrete, clinic-ready implementation framework for AI-enabled application in real-world practice. Using a digital-based voice task as an exemplar with automated feature extraction, we detail integration patterns and define key performance indicators for feasibility, data quality, usability and clinical utility. We show how this co-designed model can generate decision-relevant evidence, may help shorten time-to-action and embed innovation seamlessly into clinical workflows. Finally, we align LL operations with ethical and regulatory standards and outline strategies to responsibly scale across centres.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Clinical Neuroscience, Department of Neurology, Faculty of Medicine and University Hospital Carl Gustav Carus Dresden, TUD Dresden University of Technology, Dresden, Germany.
- Else Kröner Fresenius Center for Digital Health, TUD Dresden University of Technology, Dresden, Germany.
- Member of the Ethics Committee, TUD Dresden University of Technology, Dresden, Germany.
- Quality and Medical Risk Management, Data Security, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany.
ORCID-Profile: Hernan Inojosa, Rebecca Mathias, Isabel Voigt, Tjalf Ziemssen
Zitieren
APA
Inojosa, H., Mathias, R., Dillenseger, A., Voigt, I., Trentzsch, K., Steinigen-Fuchs, J., Piehler, K., Gilbert, S., & Ziemssen, T. (2026). AI-enabled Living Labs: Accelerating innovation in multiple sclerosis care and research. Multiple Sclerosis Journal, 32(5), 451-458. https://doi.org/10.1177/13524585261424136
Vancouver
Inojosa H, Mathias R, Dillenseger A, Voigt I, Trentzsch K, Steinigen-Fuchs J, et al. AI-enabled Living Labs: Accelerating innovation in multiple sclerosis care and research. Multiple Sclerosis Journal. 2026;32(5):451-458. doi:10.1177/13524585261424136
BibTeX
@article{Inojosa2026,
author = {Inojosa, Hernan and Mathias, Rebecca and Dillenseger, Anja and Voigt, Isabel and Trentzsch, Katrin and Steinigen-Fuchs, Julia and Piehler, Katrin and Gilbert, Stephen and Ziemssen, Tjalf},
title = {AI-enabled Living Labs: Accelerating innovation in multiple sclerosis care and research},
journal = {Multiple Sclerosis Journal},
year = {2026},
volume = {32},
number = {5},
pages = {451--458},
doi = {10.1177/13524585261424136}
}
EUVIMED